Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 21;13:1759720X21999564. doi: 10.1177/1759720X21999564

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2021

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 5. — Comparisons for DAS28 and HAQ-DI in the network meta-analysis.

The numbers below the diagonal represent the WMDs and 95% CrI of DAS28. WMDs less than 0 indicate that the drug in that column is better than the drug in that row (i.e. favor the upper treatment). The numbers above the diagonal represent the WMDs and 95% CrI of HAQ-DI. WMDs less than 0 indicate that the drug in that row is better than the drug in that column (i.e. favor the upper treatment). Significant results are in bold and underscored.

ABT, abatacept; ADA, adalimumab; Bar, baricitinib; CrI, credible interval; csDMARDs, conventional synthetic disease-modifying antirheumatic drugs; CZP, certolizumab pegol; DAS28, Disease Activity Score in 28 joints; ETN, etanercept; GOL, golimumab; HAQ-DI, Health Assessment Questionnaire–Disability Index; IFX, infliximab; PBO, placebo; RTX, rituximab; TCZ, tocilizumab; Tof, tofacitinib; Upa, upadacitinib; WMDs, weighted mean differences.